Researchers at Okayama University in Japan report that artificial-intelligence technology can detect facial charact...
Japanese firm Hitachi and American Swiss biotech company Sophia Genetics have announced that they have entere...
Bright Peak Therapeutics Inc., a biotechnology company developing next-generation immunotherapies for cancer and autoimm...
Japan Hospital Cooperative, Inc., Japan Hospital Cooperative, Inc. Ward, Representative Director Tsuneo Sakai,...
The persistent overuse of antibiotics has led to the evolution of antibiotic-resistant pathogens, or “superbugs,&r...
The Japanese pharmaceutical market is preparing for renewed international growth and partnering. In response, CPhI Japan...
Daiichi Sankyo Company, Limited has announced that it has started the first vaccinations in a phase 1/2 clinical trial i...
Japanese firm Eisai Co., Ltd. as part of its strategic investment to realize its medium-term management plan, EWAY ...
Researchers at Kanazawa University report in Review of Scientific Instruments a newly developed atomic force microscopy ...
Autoimmune diseases are typically caused when the immune system, whose purpose is to deal with foreign threats to the bo...
Epredia, a global leader in precision cancer diagnostics, and Paige, a global leader in AI-based diagnostic software in ...
Fujitsu has announced it has concluded a comprehensive collaborative research agreement with National Cancer Center Japa...
Daiichi Sankyo Company, Ltd announced on March 12, 2021, that it has started manufacturing the AstraZeneca COVID-19 vacc...
German firm Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) and Japan based Eisai have announced that b...
Takeda Pharmaceutical Company Limited has announced a reciprocal agreement with IDT Biologika GmbH (“IDT&rdqu...
Fujitsu Limited and Kyoto University research group led by Professor Yasushi Okuno of the Kyoto University Graduate Scho...
Japanese firm Takeda Pharmaceutical Company Limited has announced the exercise of its option to acquire Maverick Therape...
ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-...
